Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
暂无分享,去创建一个
M. Robson | S. Piechnik | S. Neubauer | V. Ferreira | J. Moon | P. Hawkins | M. Fontana | T. Karamitsos | S. Myerson | C. Whelan | S. Banypersad | Ntobeko A B Ntusi | N. Ntusi
[1] Stefan Neubauer,et al. Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.
[2] R. Falk,et al. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. , 2012, JACC. Cardiovascular imaging.
[3] M. Robson,et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.
[4] Marie-Pierre Jolly,et al. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation , 2012, Magnetic resonance in medicine.
[5] P. Kellman,et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.
[6] H. Niessen,et al. T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions. , 2012, Circulation. Cardiovascular imaging.
[7] J. Moon,et al. Updates in Cardiac Amyloidosis: A Review , 2012, Journal of the American Heart Association.
[8] M. Robson,et al. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.
[9] S. K. White,et al. Pre-contrast T1 mapping for detection of myocardial fibrosis in asymptomatic and symptomatic aortic stenosis , 2012, Journal of Cardiovascular Magnetic Resonance.
[10] R. Falk,et al. Cardiac Amyloidosis: A Treatable Disease, Often Overlooked , 2011, Circulation.
[11] F. Weidemann,et al. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis. , 2011, The American journal of cardiology.
[12] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[13] M. Hayward,et al. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.
[14] R. Lang,et al. Echocardiographic Evaluation of Cardiac Amyloid , 2010, Current cardiology reports.
[15] Matthew W. Martinez,et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.
[16] M. Desai,et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. , 2009, JACC. Cardiovascular imaging.
[17] D. Pennell,et al. Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[18] Michael Jerosch-Herold,et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.
[19] K. Klingel,et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.
[20] S. Neubauer,et al. Evaluation and management of the cardiac amyloidosis. , 2007, Journal of the American College of Cardiology.
[21] H. Kauczor,et al. MR-Relaxometry of Myocardial Tissue: Significant Elevation of T1 and T2 Relaxation Times in Cardiac Amyloidosis , 2007, Investigative radiology.
[22] J. Francis,et al. Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. , 2007, Journal of Cardiovascular Magnetic Resonance.
[23] M. Salvadori,et al. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] R. Günther,et al. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects , 2007, Journal of magnetic resonance imaging : JMRI.
[25] G. Merlini,et al. Dangerous small B-cell clones. , 2006, Blood.
[26] R. Falk. Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.
[27] F. Salvi,et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. , 2005, Journal of the American College of Cardiology.
[28] R. Falk,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis , 2005, American journal of hematology.
[29] A. Tajik,et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. , 2005, The American journal of cardiology.
[30] R. Falk,et al. Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.
[31] It Istituto Superiore di Sanit,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from th 10th International Symposium on Amyloid an Amyloidosis, Tours, France, 18-22 April 2004 , 2005 .
[32] T. Therneau,et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] E. McVeigh,et al. Phase‐sensitive inversion recovery for detecting myocardial infarction using gadolinium‐delayed hyperenhancement † , 2002, Magnetic resonance in medicine.
[34] R. Falk,et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. , 1998, QJM : monthly journal of the Association of Physicians.
[35] R. Kyle,et al. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. , 1995, Seminars in hematology.
[36] M. Pepys,et al. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. , 1990, The New England journal of medicine.
[37] A. Ericsson,et al. Magnetic Resonance Imaging in Primary Amyloidosis , 1987, Acta radiologica.